Lung Cancer and Lung Transplantation

Timothy Brand; Benjamin Haithcock

doi:10.1016/j.thorsurg.2017.09.003

Lung Cancer and Lung Transplantation

Thorac Surg Clin. 2018 Feb;28(1):15-18. doi: 10.1016/j.thorsurg.2017.09.003.

Authors

Timothy Brand¹, Benjamin Haithcock²

Affiliations

¹ Division of Cardiothoracic Surgery, Department of Surgery, University of North Carolina, Chapel Hill, NC, USA.
² Division of Cardiothoracic Surgery, Department of Surgery, University of North Carolina, Chapel Hill, NC, USA. Electronic address: benjamin_haithcock@med.unc.edu.

PMID: 29150033
DOI: 10.1016/j.thorsurg.2017.09.003

Abstract

Lung transplantation remains a viable option for patients with endstage pulmonary disease. Despite removing the affected organ and replacing both lungs, the risk of lung malignancies still exists. Regardless of the mode of entry, lung cancer affects the prognosis in these patients and diligence is required.

Keywords: Immunosuppression; Lung transplantation; Malignancy.

Publication types

Review

MeSH terms

Humans
Immunosuppression Therapy / adverse effects
Incidental Findings
Lung Neoplasms / diagnosis*
Lung Neoplasms / etiology
Lung Neoplasms / surgery*
Lung Transplantation* / adverse effects
Postoperative Complications / etiology
Prognosis